Lannett Co Price Target Increased to $23.50 by Analysts at Roth Capital (LCI)
Research analysts at Roth Capital hoisted their target price on shares of Lannett Co (AMEX:LCI) from $18.50 to $23.50 in a report released on Thursday, StockRatingsNetwork reports. The firm currently has a “buy” rating on the stock. Roth Capital’s price target points to a potential upside of 23.88% from the stock’s previous close.
Lannett Co (AMEX:LCI) traded up 5.62% on Thursday, hitting $18.97. 565,338 shares of the company’s stock traded hands. Lannett Co has a 52 week low of $3.93 and a 52 week high of $23.42. The stock’s 50-day moving average is $16.94 and its 200-day moving average is $13.21. The company has a market cap of $576.5 million and a P/E ratio of 39.04.
A number of other analysts have also recently weighed in on LCI. Analysts at Needham & Company downgraded shares of Lannett Co from a “buy” rating to a “hold” rating in a research note to investors on Friday, October 4th. Separately, analysts at Canaccord Genuity raised their price target on shares of Lannett Co from $16.00 to $18.00 in a research note to investors on Wednesday, September 11th. They now have a “buy” rating on the stock. Finally, analysts at Oppenheimer initiated coverage on shares of Lannett Co in a research note to investors on Monday, September 9th. They set an “outperform” rating and a $20.00 price target on the stock.
Lannett Company, Inc is engaged in developing, manufacturing, marketing and distributing generic versions of branded pharmaceutical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.